wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33732593-494884DB-4488-4C6A-91A9-276AC0B27722
Q33732593-494884DB-4488-4C6A-91A9-276AC0B27722
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33732593-494884DB-4488-4C6A-91A9-276AC0B27722
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK.
P2860
Q33732593-494884DB-4488-4C6A-91A9-276AC0B27722
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33732593-494884DB-4488-4C6A-91A9-276AC0B27722
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c627e8dcb20de75a098ef8a4bf5d948bf09b1ceb
P2860
Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway.